Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-24-037241

Chief Scientific Officer sold 190,476 shares at $21.50 ($4,095,234)

  • Chief Scientific Officer gave up 11,197 shares (to pay taxes)
  • Chief Scientific Officer acquired 201,673 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kastelein Johannes Jacob Pieter · Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-26 Exercise or conversion : show line 1 in the form +201,673 201,673 I
2024-03-26 Shares withheld for taxes : show line 2 in the form −11,197 $22.72 $254,396 190,476 I
2024-03-26 Sale : show line 3 in the form −190,476 $21.50 $4,095,234 0 I
Open-market sales · 190,476 sh · avg $21.50 · $4,095,234

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-03-26 Exercise or conversion : show line 4 in the form Option (right to buy) −201,673 970,229 I
Loading xslF345X05/ownership.xml…